Effect of Choline Fenofibrate (SLV348) on Macular Edema Measured by Optical Coherence Tomography in Subjects With Diabetic Macular Edema - a One-Year, Placebo-Controlled, Randomized Study.

Trial Profile

Effect of Choline Fenofibrate (SLV348) on Macular Edema Measured by Optical Coherence Tomography in Subjects With Diabetic Macular Edema - a One-Year, Placebo-Controlled, Randomized Study.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Nov 2012

At a glance

  • Drugs Choline fenofibrate (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jun 2012 Fournier Laboratories Ireland added as sponsor and lead trial centre as reported by European Clinical Trials Database.
    • 23 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Dec 2010 Actual initiation date changed from 1 Sep 2008 to 1 Oct 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top